Erratum: CD40 Activation Rescues Antiviral CD8+T Cells from PD-1-Mediated Exhaustion (PLoS Pathogens (2013) 9:7 (e1003490) DOI: 10.1371/journal.ppat.1003490);CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Isogawa, Masanori ^a   Chung, Josan ^a   Murata, Yasuhiro ^a   Kakimi, Kazuhiro ^a   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD40 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CLODRONIC ACID; DIPHTHERIA TOXIN; DNA; GAMMA INTERFERON; GRANZYME B; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; PROGRAMMED DEATH 1 RECEPTOR; RNA; VIRUS ENVELOPE PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; GENE EXPRESSION; HEPATITIS B VIRUS; IMMUNE RESPONSE; LIVER CELL DAMAGE; MALE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SOUTHERN BLOTTING; VACCINIA VIRUS; VIRUS NUCLEOCAPSID;

ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 84884797950     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006086     Document Type: Erratum

References (76)

1. Williams M, Bevan M, (2007) Effector and memory CTL differentiation. Annu Rev Immunol 25: 171-192.
2. Sprent J, Surh CD, (2002) T Cell Memory. Annual Review of Immunology 20: 551-579 Available: http://dxdoiorg/101146/annurevimmunol20100101151926.
3. Crispe I, (2003) Hepatic T cells and liver tolerance. Nat Rev Immunol 3: 51-62.
4. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV, (1994) CTL access to tissue antigen is restricted in vivo. J Immunol 153: 482-488.
5. Zakim D, Boyer TD (2003) Hepatology. W B Saunders Co. 1 pp.
6. Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, et al. (2006) T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44: 1182-1190 doi:10.1002/hep.21378.
7. Limmer A, Ohl J, Wingender G, Berg M, Jungerkes F, et al. (2005) Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur J Immunol 35: 2970-2981.
8. Limmer A, Ohl J, Kurts C, Ljunggren H, Reiss Y, et al. (2000) Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6: 1348-1354.
9. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, et al. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26: 117-129 doi:10.1016/j.immuni.2006.11.011.
10. You Q, Cheng L, Kedl RM, Ju C, (2008) Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 48: 978-990 doi:10.1002/hep.22395.
11. Breous E, Somanathan S, Vandenberghe LH, Wilson JM, (2009) Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology 50: 612-621 doi:10.1002/hep.23043.
12. Xia S, Guo Z, Xu X, Yi H, Wang Q, et al. (2008) Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood 112: 3175-3185 doi:10.1182/blood-2008-05-159921.
13. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, et al. (2009) Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 182: 1901-1911 doi:10.4049/jimmunol.0803404.
14. Goubier A, Dubois B, Gheit H, Joubert G, Villard-Truc F, et al. (2008) Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29: 464-475 doi:10.1016/j.immuni.2008.06.017.
15. Bertolino P, Bowen DG, McCaughan GW, Fazekas de St Groth B, (2001) Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol 166: 5430-5438.
16. Chisari FV, Ferrari C, (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13: 29-60 doi:10.1146/annurev.iy.13.040195.000333.
17. Ganem D, Prince AM, (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-1129 doi:10.1056/NEJMra031087.
18. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, et al. (2003) CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77: 68-76.
19. Guidotti LG, Matzke B, Schaller H, Chisari FV, (1995) High-level hepatitis B virus replication in transgenic mice. J Virol 69: 6158-6169.
20. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, et al. (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4: 25-36.
21. Isogawa M, Furuichi Y, Chisari FV, (2005) Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity 23: 53-63 doi:10.1016/j.immuni.2005.05.005.
22. Berard M, Tough DF, (2002) Qualitative differences between naïve and memory T cells. Immunology 106: 127-138.
23. Sigal LJ, Crotty S, Andino R, Rock KL, (1999) Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398: 77-80 doi:10.1038/18038.
24. Heath WR, Carbone FR, (2001) Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1: 126-134 doi:10.1038/35100512.
25. Kakimi K, Isogawa M, Chung J, Sette A, Chisari FV, (2002) Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J Virol 76: 8609-8620.
26. Kouskoff V, Signorelli K, Benoist C, Mathis D, (1995) Cassette vectors directing expression of T cell receptor genes in transgenic mice. J Immunol Methods 180: 273-280.
27. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, et al. (1993) Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178: 1541-1554.
28. Ishikawa T, Kono D, Chung J, Fowler P, Theofilopoulos A, et al. (1998) Polyclonality and multispecificity of the CTL response to a single viral epitope. J Immunol 161: 5842-5850.
29. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, et al. (1994) Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 152: 3245-3253.
30. Schlicht H, Schaller H, (1989) The secretory core protein of human hepatitis B virus is expressed on the cell surface. J Virol 63: 5399-5404.
31. Keir ME, Freeman GJ, Sharpe AH, (2007) PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues. J Immunol 179: 5064-5070.
32. Lin JX, Leonard WJ, (1997) Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev 8: 313-332.
33. Lepault F, Gagnerault MC, Faveeuw C, Boitard C, (1994) Recirculation, phenotype and functions of lymphocytes in mice treated with monoclonal antibody MEL-14. Eur J Immunol 24: 3106-3112 doi:10.1002/eji.1830241229.
34. Mempel T, Henrickson S, Andrian von U, (2004) T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427: 154-159.
35. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, et al. (2004) The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114: 701-712 doi:10.1172/JCI21593.
36. Thomson AW, Knolle PA, (2010) Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 10: 753-766 doi:10.1038/nri2858.
37. Guidotti L, Martinez V, Loh Y, Rogler C, Chisari F, (1994) Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J Virol 68: 5469-5475.
38. Castellino F, Germain R, (2006) Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol 24: 519-540.
39. Bertolino P, Trescol-Biémont MC, Rabourdin-Combe C, (1998) Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol 28: 221-236 doi:;10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.0.CO;2-F.
40. Heath WR, Bennett SRM, Carbone FR, Karamalis F, Flavell RA, et al. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480 doi:10.1038/30996.
41. Ridge JP, Di Rosa F, Matzinger P, (1998) A conditioned dendritic cell can be a temporal bridge between a CD4{pipe}[plus]{pipe} T-helper and a T-killer cell. Nature 393: 474-478 doi:10.1038/30989.
42. Schoenberger SP, Toes REM, van der Voort EIH, Offringa R, Melief CJM, (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483 doi:10.1038/31002.
43. Rolink A, Melchers F, Andersson J, (1996) The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5: 319-330.
44. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV, (2002) Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 169: 5188-5195.
45. Hochweller K, Striegler J, Hämmerling GJ, Garbi N, (2008) A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur J Immunol 38: 2776-2783 doi:10.1002/eji.200838659.
46. Rooijen NV, Sanders A, (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. Journal of Immunological Methods 174: 83-93 doi:10.1016/0022-1759(94)90012-4.
47. Naito MM, Nagai HH, Kawano SS, Umezu HH, Zhu HH, et al. (1996) Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. J Leukoc Biol 60: 337-344.
48. Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, et al. (1987) Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A 84: 6909-6913.
49. Maier H, Isogawa M, Freeman GJ, Chisari FV, (2007) PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol 178: 2714-2720.
50. Diehl L, Schurich A, Grochtmann R, Hegenbarth S, Chen L, et al. (2008) Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 47: 296-305 doi:10.1002/hep.21965.
51. Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, et al. (2010) Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138: 682-.e4, 682-693, 693.e1-.e4 doi:10.1053/j.gastro.2009.09.052.
52. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270: 985-988.
53. Jin H-T, Anderson AC, Tan WG, West EE, Ha S-J, et al. (2010) Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 107: 14733-14738 doi:10.1073/pnas.1009731107.
54. Sánchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, et al. (2003) Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4: 1093-1101 doi:10.1038/ni987.
55. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, et al. (2003) Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4: 1102-1110 doi:10.1038/ni988.
56. West EE, Youngblood B, Tan WG, Jin H-T, Araki K, et al. (2011) Tight Regulation of Memory CD8+ T Cells Limits Their Effectiveness during Sustained High Viral Load. Immunity 35: 285-298 doi:10.1016/j.immuni.2011.05.017.
57. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29-37 doi:10.1038/ni.1679.
58. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301-1309 doi:10.1038/nm1492.
59. Brooks DG, Walsh KB, Elsaesser H, Oldstone MBA, (2010) IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Proc Natl Acad Sci USA 107: 3018-3023 doi:10.1073/pnas.0914500107.
60. Li MO, Sanjabi S, Flavell RA, (2006) Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25: 455-471 doi:10.1016/j.immuni.2006.07.011.
61. Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI, (2009) Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 31: 145-157 doi:10.1016/j.immuni.2009.06.015.
62. Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, et al. (2012) Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE 7: e47648 doi:10.1371/journal.pone.0047648.
63. Raziorrouh B, Schraut W, Gerlach T, Nowack D, Grüner NH, et al. (2010) The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 52: 1934-1947 doi:10.1002/hep.23936.
64. Schurich A, Khanna P, Lopes AR, Han KJ, Peppa D, et al. (2011) Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 53: 1494-1503 doi:10.1002/hep.24249.
65. Curtsinger JM, Lins DC, Mescher MF, (2003) Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 197: 1141-1151 doi:10.1084/jem.20021910.
66. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K, (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650 doi:10.1084/jem.20050821.
67. Schurich A, Pallett LJ, Lubowiecki M, Singh HD, Gill US, et al. (2013) The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells. PLOS Pathogens 9: e1003208 doi:10.1371/journal.ppat.1003208.s008.
68. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, et al. (2007) Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81: 4215-4225 doi:10.1128/JVI.02844-06.
69. Reignat S, Webster GJM, Brown D, Ogg GS, King A, et al. (2002) Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 195: 1089-1101.
70. Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, et al. (2009) The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol 83: 9652-9662 doi:10.1128/JVI.00867-09.
71. Kuhrober A, Wild J, Pudollek HP, Chisari FV, Reimann J, (1997) DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int Immunol 9: 1203-1212.
72. Smith G, Mackett M, Moss B, (1983) Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302: 490-495.
73. Yoshida R, Yoshioka T, Yamane S, Matsutani T, Toyosaki-Maeda T, et al. (2000) A new method for quantitative analysis of the mouse T-cell receptor V region repertoires: comparison of repertoires among strains. Immunogenetics 52: 35-45.
74. Isogawa M, Kakimi K, Kamamoto H, Protzer U, Chisari FV, (2005) Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. Virology 333: 293-300 doi:10.1016/j.virol.2005.01.004.
75. Hösel M, Broxtermann M, Janicki H, Esser K, Arzberger S, et al. (2011) TLR2-mediated innate immune response in human non-parenchymal liver cells towards adeno-associated viral (AAV) vectors. Hepatology doi:10.1002/hep.24625.
76. Schrage A, Loddenkemper C, Erben U, Lauer U, Hausdorf G, et al. (2008) Murine CD146 is widely expressed on endothelial cells and is recognized by the monoclonal antibody ME-9F1. Histochem Cell Biol 129: 441-451 doi:10.1007/s00418-008-0379-x.